network. experience. benefit.
ECA - The new EU Annex 1 Draft
25. April 2018
This is why you may want to attend this conference:
- You get to know the content of the revised EU GMP Annex 1.
- Inspectors and pharmaceutical operators discuss the consequences of the changes for the operational processes.
- The new EU GMP Guide Annex 1
- New terminology used in the Annex 1 draft
- Pharma Industry’s perspective on the revision of EU GMP Annex 1
- Environmental Monitoring / Media Fills – new challenges
- Discussion: Annex 1 revision – challenges for the industry?
- James Drinkwater, The Pharmaceutical & Healthcare Sciences Society
- Dr. Friedrich Haefele, Boehringer Ingelheim Pharma
- Arjan Langen, MSD Animal Health
- Dr. Jean-Denis Mallet, ECA & Former Head of the French Pharmaceutical Inspection Dpt. AFSSAPS
- Dr. Daniel Müller, GMP Inspector, Local Authority of Baden Württemberg
- Dr. Beate Reutter, GMP Inspector Local Government Schleswig-Holstein
- Alexandra Stärk, Novartis Pharma
Get a complete overview in the Schedule.